Utah Medical Products, Inc. (NASDAQ:UTMD) Shares Purchased by Lazard Asset Management LLC

Lazard Asset Management LLC lifted its holdings in Utah Medical Products, Inc. (NASDAQ:UTMDGet Rating) by 63.7% in the second quarter, Holdings Channel reports. The firm owned 1,370 shares of the medical instruments supplier’s stock after buying an additional 533 shares during the period. Lazard Asset Management LLC’s holdings in Utah Medical Products were worth $117,000 as of its most recent SEC filing.

A number of other institutional investors have also recently made changes to their positions in UTMD. Isthmus Partners LLC boosted its position in shares of Utah Medical Products by 6.1% in the 1st quarter. Isthmus Partners LLC now owns 18,605 shares of the medical instruments supplier’s stock worth $1,672,000 after purchasing an additional 1,071 shares in the last quarter. Russell Investments Group Ltd. raised its stake in Utah Medical Products by 4.0% in the 1st quarter. Russell Investments Group Ltd. now owns 81,658 shares of the medical instruments supplier’s stock worth $7,336,000 after acquiring an additional 3,160 shares during the last quarter. HealthInvest Partners AB raised its stake in Utah Medical Products by 40.0% in the 1st quarter. HealthInvest Partners AB now owns 56,000 shares of the medical instruments supplier’s stock worth $5,032,000 after acquiring an additional 16,000 shares during the last quarter. JPMorgan Chase & Co. raised its stake in Utah Medical Products by 16.9% in the 1st quarter. JPMorgan Chase & Co. now owns 101,769 shares of the medical instruments supplier’s stock worth $9,145,000 after acquiring an additional 14,693 shares during the last quarter. Finally, Bank of New York Mellon Corp raised its stake in Utah Medical Products by 2.0% in the 1st quarter. Bank of New York Mellon Corp now owns 19,948 shares of the medical instruments supplier’s stock worth $1,793,000 after acquiring an additional 389 shares during the last quarter. Institutional investors and hedge funds own 61.51% of the company’s stock.

Wall Street Analyst Weigh In

Separately, StockNews.com began coverage on Utah Medical Products in a research note on Wednesday, October 12th. They issued a “strong-buy” rating for the company.

Utah Medical Products Price Performance

Shares of UTMD stock opened at $92.78 on Wednesday. The firm has a market capitalization of $336.61 million, a price-to-earnings ratio of 21.13 and a beta of 0.30. The business has a fifty day moving average of $88.03 and a 200 day moving average of $87.21. Utah Medical Products, Inc. has a 1 year low of $80.10 and a 1 year high of $131.48.

Utah Medical Products Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Wednesday, January 4th. Investors of record on Friday, December 16th will be paid a $0.295 dividend. This is a positive change from Utah Medical Products’s previous quarterly dividend of $0.29. The ex-dividend date of this dividend is Thursday, December 15th. This represents a $1.18 dividend on an annualized basis and a yield of 1.27%. Utah Medical Products’s dividend payout ratio (DPR) is 26.42%.

About Utah Medical Products

(Get Rating)

Utah Medical Products, Inc develops, manufactures, and distributes medical devices for the healthcare industry. The company offers fetal monitoring accessories, vacuum-assisted delivery systems, and other labor and delivery tools; DISPOSA-HOOD infant respiratory hoods; and DELTRAN PLUS blood pressure monitoring systems.

Further Reading

Want to see what other hedge funds are holding UTMD? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Utah Medical Products, Inc. (NASDAQ:UTMDGet Rating).

Institutional Ownership by Quarter for Utah Medical Products (NASDAQ:UTMD)

Receive News & Ratings for Utah Medical Products Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Utah Medical Products and related companies with MarketBeat.com's FREE daily email newsletter.